MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · IEX Real-Time Price · USD
0.689
-0.097 (-12.37%)
At close: Jul 19, 2024, 4:00 PM
0.661
-0.028 (-4.05%)
Pre-market: Jul 22, 2024, 7:06 AM EDT
MIRA Pharmaceuticals Employees
MIRA Pharmaceuticals had 3 employees as of March 28, 2024. The number of employees decreased by 3 or -50.00% since the number was reported on July 21, 2023.
Employees
3
Change
-3
Growth
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$4,119,691
Market Cap
10.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 28, 2024 | 3 | -3 | -50.00% |
| Jul 21, 2023 | 6 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 103 |
| Mustang Bio | 80 |
| Pieris Pharmaceuticals | 50 |
| Dominari Holdings | 28 |
| Plus Therapeutics | 20 |
| ABVC BioPharma | 19 |
| Traws Pharma | 18 |
| Moleculin Biotech | 18 |
MIRA News
- 7 days ago - Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC - Accesswire
- 27 days ago - MIRA Pharmaceuticals Announces Ketamir-2 Shows Promising Safety Profile in Comparison to Traditional Ketamine In Preclinical Testing - PRNewsWire
- 4 weeks ago - MIRA Announces Positive Test Results - Benzinga
- 5 weeks ago - Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year - PRNewsWire
- 7 weeks ago - Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance - PRNewsWire
- 2 months ago - MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog - PRNewsWire
- 2 months ago - Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog - PRNewsWire
- 3 months ago - Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission - PRNewsWire